TORTELLINI, EEVA
 Distribuzione geografica
Continente #
EU - Europa 211
NA - Nord America 79
AS - Asia 61
AF - Africa 4
Totale 355
Nazione #
IT - Italia 179
US - Stati Uniti d'America 78
SG - Singapore 41
ID - Indonesia 10
BG - Bulgaria 7
IE - Irlanda 7
GB - Regno Unito 4
SE - Svezia 4
FI - Finlandia 3
IN - India 3
PH - Filippine 3
CN - Cina 2
DE - Germania 2
FR - Francia 2
HK - Hong Kong 2
NG - Nigeria 2
AL - Albania 1
CA - Canada 1
MA - Marocco 1
NL - Olanda 1
RO - Romania 1
TN - Tunisia 1
Totale 355
Città #
Rome 74
Milan 29
Singapore 25
Ashburn 14
New York 12
Jakarta 10
Artena 7
Dublin 7
Sofia 7
Santa Clara 6
Ascoli Piceno 5
Boardman 4
Chandler 4
Dasmariñas 3
Padova 3
Portland 3
Sabaudia 3
Treviso 3
Abuja 2
Bologna 2
Crevalcore 2
Des Moines 2
Genoa 2
Helsinki 2
Hong Kong 2
London 2
Munich 2
Negrar 2
Porto Recanati 2
Pune 2
Rho 2
Romainville 2
Seattle 2
Acton 1
Anandanagar 1
Andover 1
Ardesio 1
Civita Castellana 1
Fairfield 1
Iesi 1
Kilburn 1
Lappeenranta 1
Latina 1
Los Angeles 1
Mondragone 1
Naples 1
Pescara 1
Prato 1
Princeton 1
Salerno 1
Saviano 1
Seriate 1
Toronto 1
Trumbull 1
Vallefoglia 1
Verona 1
Woodbridge 1
Totale 273
Nome #
Use of remdesivir in patients with SARS-CoV-2 Pneumonia in a real-life setting during the second and third COVID-19 epidemic waves 56
Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine 50
Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients 50
Evaluation of immunogenicity to three doses of the SARS-CoV-2 BNT162b2 mRNA vaccine in lung transplant patients 48
Quality of t-cell response to SARS-CoV-2 mrrna vaccine in art-treated plwh 36
Systemic, mucosal immune activation and psycho-sexual health in art-suppressed women living with HIV. Evaluating biomarkers and environmental stimuli 31
Longitudinal virological and immunological profile in a case of human monkeypox infection 31
Immunogenicity and efficacy of vaccination in people living with human immunodeficiency virus 28
Effectiveness, Tolerability and Prescribing Choice of Antiviral Molecules Molnupiravir, Remdesivir and Nirmatrelvir/r: A Real-World Comparison in the First Ten Months of Use 28
The long-term Immunogenicity of mRNABNT162b third vaccine dose in solid organ transplant recipients 15
null 9
Effectiveness, tolerability and prescribing choice of antiviral molecules molnupiravir, remdesivir and nirmatrelvir/r. A real-world comparison in the first ten months of use 9
null 3
null 3
Totale 397
Categoria #
all - tutte 2.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.676


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210 0 0 0 0 0 0 0 0 0 0 9 1
2022/2023102 2 1 2 11 14 17 9 9 5 0 16 16
2023/2024198 9 7 5 20 18 39 13 8 1 35 15 28
2024/202587 11 3 12 36 25 0 0 0 0 0 0 0
Totale 397